Document Type : Research articles

Authors

Department of General Surgery, University of Trakya, Faculty of Medicine, Edirne, Turkey

Abstract

Background: The first case of COVID-19 infection in Turkey was reported on March 11th, 2020, and declared a pandemic by the World Health Organization (WHO) in March 2020, introducing new regulations to national health systems. Some patients with non-COVID-19 presentations may have been adversely affected by this pandemic.
Objectives: The present study aimed to investigate the effect of COVID-19 on patients with Fournier's gangrene during the pandemic and the impact of the COVID-19 pandemic on the clinical management and patient outcomes for Fournier's gangrene.
Methods: This retrospective cross-sectional study was conducted between March 2018 and March 2022 at the General Surgery Department of Trakya University. Patients were stratified into pre-pandemic and pandemic groups based on the date of March 11th, 2020, when the first Covid-19 case was reported in Turkey. Data collection and retrospective analysis were completed for all patients who were operated on for Fournier's gangrene originating from the perianal region. Demographic characteristics, predisposing factors, as well as laboratory and clinical results of the patients treated during the pandemic, were compared with the patients treated before the pandemic.
Results: A total of 43 patients were included in the study (pre-pandemic: 24, pandemic: 19). There was a statistically significant difference between the pre-pandemic and pandemic groups in terms of the median length of hospital stay (7 vs. 16 days, p<0.001) and the median number of debridement (4 vs. 2, p=0.002).
Conclusion: In the presence of life-threatening surgical pathologies, such as Fournier's gangrene, the number of admissions did not decrease despite the pandemic. Precautions taken to reduce the risk of transmission in pandemic conditions and more aggressive surgical applications can reduce the number of debridement procedures and shorten the length of hospital stay. Subsequently, this is associated with similar treatment outcomes, lower morbidity, and reduced treatment costs.

Keywords

  1. Søreide K, Hallet J, Matthews JB, Schnitzbauer AA, Line PD, Lai PB, et al. Immediate and long-term impact of the COVID-19 pandemic on delivery of surgical services. Br J Surg. 2020;107(10):1250–61. doi: 10.1002/bjs.11670. [PubMed: 32350857].
  2. Ti LK, Ang LS, Foong TW, Ng BS. What we do when a COVID-19 patient needs an operation: operating room preparation and guidance. Can J Anaesth. 2020;67(6):756–8. doi: 10.1007/s12630-020-01617-4. [PubMed: 32144591].
  3. Kuitunen I, Ponkilainen VT, Launonen AP, Reito A, Hevonkorpi TP, Paloneva J, et al. The effect of national lockdown due to COVID-19 on emergency department visits. Scand J Trauma Resusc Emerg Med. 2020;28(1):114. doi: 10.1186/s13049-020-00810-0. [PubMed: 33276799].
  4. Norton KS, Johnson LW, Perry T, Perry KH, Sehon JK, Zibari GB. Management of Fournier's gangrene: an eleven year retrospective analysis of early recognition, diagnosis, and treatment. Am Surg. 2002;68(8):709–13. [PubMed: 12206606].
  5. Şahiner IT, Kendirci M, Dolapçı M. Evaluation of patients with a diagnosis of necrotizing fasciitis within the last year. Dicle Med J. 2017;44:271–6. doi: 10.5798/dicletip.339011.
  6. Sökmen S. Fournier’s gangrene. ANKEM J. 2012;26:331–6.
  7. Kaya E, Yılmaz S, Ebiloğlu T, Kangal KO, Bedir S, Zor M. A multistep approach in fournier's gangrene management: serial surgical debridement, protective colostomy, vacuum assisted closure therapy and hyperbaric oxygen treatment. New J Urol. 2018;13(1):56–9.
  8. Sehmi S, Osaghae S. Type II diabetes mellitus: new presentation manifesting as fournier’s gangrene. JRSM Short Rep. 2011;2(6):51–6. doi: 10.1258/shorts.2011.011055.
  9. Osbun N, Hampson LA, Holt SK, Gore JL, Wessells H, Voelzke BB. Low-volume vs high-volume centers and management of fournier's gangrene in washington state. J Am Coll Surg. 2017;224(3):270-5. doi: 10.1016/j.jamcollsurg.2016.11.012. [PubMed: 27965132].
  10. Oymacı E, Coşkun A, Yakan S, Erkan N, Uçar AD, Yıldırım M. Evaluation of factors affecting mortality in Fournier's Gangrene: retrospective clinical study of sixteen cases. Ulus Cerrahi Derg. 2014;30(2):85–9. doi: 10.5152/UCD.2014.2512. [PubMed: 25931901].
  11. COVID-19: Guidance for triage of non-emergent surgical procedures. 2020. Available from: https://www.facs.org/covid-19/clinical-guidance/triage
  12. Clinical guide to surgical prioritisation during
  13. the coronavirus pandemic. 2020. https://www.england.nhs.uk/coronavirus/wpcontent/uploads/sites/52/2020/03/C0221-specialty-guide-surgical-prioritisation-v1.pdf
  14. Çelik SU, Çetinkaya ÖA, Tüzüner A. Surgery and COVID-19. Yalçın Ş, Özet A, editörler. Cancer and COVID-19 Pandemic. Ankara: Turkey Clinics; 2020.
  15. Guidance for surgeons working during the COVID-19 pandemic. Royal Collage of Surgeons. 2020. Available from: https://www.rcseng.ac.uk/coronavirus/joint-guidance-for-surgeons/
  16. Cantay H, Anuk T, Dogan G, Eren MS, Gonullu D. Effects of Covid-19 pandemic on general surgery emergency protocol. Kocaeli Med J. 2021;10(1):56–60. doi: 10.5505/ktd.2021.58224.
  17. Turanli S, Kiziltan G. Did the COVID-19 pandemic cause a delay in the diagnosis of acute appendicitis? World J Surg. 2021;45(1):18–22. doi: 10.1007/s00268-020-05825-3. [PubMed: 33089347].
  18. McGuinness MJ, Harmston C. The effect of national public health interventions for COVID-19 on emergency general surgery in Northland, New Zealand. ANZ J Surg. 2021;91(3):329–34. doi: 10.1111/ans.16562. [PubMed: 33475217].
  19. Yılmazlar T, Işık Ö, Öztürk E, Özer A, Gülcü B, Ercan İ. Fournier's gangrene: review of 120 patients and predictors of mortality. Ulus Travma Acil Cerrahi Derg. 2014;20(5):333–7. doi: 10.5505/tjtes.2014.06870. [PubMed: 25541844].
  20. Yim SU, Kim SW, Ahn JH, Cho YH, Chung H, Hwang EC, et al. Neutrophil to lymphocyte and platelet to lymphocyte ratios are more effective than the fournier's gangrene
  21. severity ındex for predicting poor prognosis in fournier's gangrene. Surg Infect (Larchmt). 2016;17(2):217–23. doi: 10.1089/sur.2015.126. [PubMed: 26835748].
  22. Zuhour M, Dadacı M, Baycar Z, İnce B, Soylu A. Fournier's gangrene as a possible surgical complication of COVID‐19: two case reports and literature review. Turk J Plast Surg. 2022;30(1):17–20.
  23. Lauerman MH, Kolesnik O, Sethuraman K, Rabinowitz R, Joshi M, Clark E, et al. Less is more? Antibiotic duration and outcomes in Fournier's gangrene. J Trauma Acute Care Surg. 2017;83(3):443-8. doi: 10.1097/TA.0000000000001562. [PubMed: 28538648].
  24. Yücel M, Özpek A, Başak F, Kılıç A, Ünal E, Yüksekdağ S, et al. Fournier's gangrene: A retrospective analysis of 25 patients. Ulus Travma Acil Cerrahi Derg. 2017;23(5):400–4. doi: 10.5505/tjtes.2017.01678. [PubMed: 29052826].
  25. Bronder CS, Cowey A, Hill J. Delayed stoma formation in Fournier’s gangrene. Colorectal Dis. 2004;6(6):518–20. doi: 10.1111/j.1463-1318.2004.00663.x. [PubMed: 15521946].
  26. Ozturk E, Sonmez Y, Yilmazlar T. What are the indications for a stoma in Fournier’s gangrene? Colorectal Dis. 2011;13(9):1044–7. doi: 10.1111/j.1463-1318.2010.02353.x. [PubMed: 20579084].